These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33577386)

  • 1. Low-Dose Trazodone for Delirium in Patients with Cancer Who Received Specialist Palliative Care: A Multicenter Prospective Study.
    Maeda I; Inoue S; Uemura K; Tanimukai H; Hatano Y; Yokomichi N; Amano K; Tagami K; Yoshiuchi K; Ogawa A; Iwase S;
    J Palliat Med; 2021 Jun; 24(6):914-918. PubMed ID: 33577386
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and Effectiveness of Perospirone in Comparison to Risperidone for Treatment of Delirium in Patients with Advanced Cancer: A Multicenter Prospective Observational Study in Real-World Psycho-Oncology Settings.
    Inoue S; Maeda I; Ogawa A; Yoshiuchi K; Terada S; Yamada N
    Acta Med Okayama; 2022 Apr; 76(2):195-202. PubMed ID: 35503448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings.
    Maeda I; Ogawa A; Yoshiuchi K; Akechi T; Morita T; Oyamada S; Yamaguchi T; Imai K; Sakashita A; Matsumoto Y; Uemura K; Nakahara R; Iwase S;
    Gen Hosp Psychiatry; 2020; 67():35-41. PubMed ID: 32950826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decision tree prediction model for a short-term outcome of delirium in patients with advanced cancer receiving pharmacological interventions: A secondary analysis of a multicenter and prospective observational study (Phase-R).
    Kurisu K; Inada S; Maeda I; Ogawa A; Iwase S; Akechi T; Morita T; Oyamada S; Yamaguchi T; Imai K; Nakahara R; Kaneishi K; Nakajima N; Sumitani M; Yoshiuchi K;
    Palliat Support Care; 2022 Apr; 20(2):153-158. PubMed ID: 35574912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients?
    Uchida M; Morita T; Akechi T; Yokomichi N; Sakashita A; Hisanaga T; Matsui T; Ogawa A; Yoshiuchi K; Iwase S;
    Psychooncology; 2020 Nov; 29(11):1842-1849. PubMed ID: 32735046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan.
    Morita T; Chinone Y; Ikenaga M; Miyoshi M; Nakaho T; Nishitateno K; Sakonji M; Shima Y; Suenaga K; Takigawa C; Kohara H; Tani K; Kawamura Y; Matsubara T; Watanabe A; Yagi Y; Sasaki T; Higuchi A; Kimura H; Abo H; Ozawa T; Kizawa Y; Uchitomi Y;
    J Pain Symptom Manage; 2005 Oct; 30(4):320-8. PubMed ID: 16256896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology matter?
    Matsuda Y; Maeda I; Morita T; Yamauchi T; Sakashita A; Watanabe H; Kaneishi K; Amano K; Iwase S; Ogawa A; Yoshiuchi K;
    Cancer Med; 2020 Jan; 9(1):19-26. PubMed ID: 31696671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Delirium in Corticosteroid-Treated Patients with Advanced Cancer: An Exploratory, Multicenter, Prospective, Observational Study.
    Matsuo N; Morita T; Matsuda Y; Okamoto K; Matsumoto Y; Kaneishi K; Odagiri T; Sakurai H; Katayama H; Mori I; Yamada H; Watanabe H; Yokoyama T; Yamaguchi T; Nishi T; Shirado A; Hiramoto S; Watanabe T; Kohara H; Shimoyama S; Aruga E; Baba M; Sumita K; Iwase S
    J Palliat Med; 2017 Apr; 20(4):352-359. PubMed ID: 28379811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prevalence and associated factors of hyperactive delirium in advanced cancer patients between inpatient palliative care and palliative home care.
    Hamano J; Mori M; Ozawa T; Sasaki J; Kawahara M; Nakamura A; Hashimoto K; Hisajima K; Koga T; Goto K; Fukumoto K; Morimoto Y; Goshima M; Sekimoto G; Baba M; Oya K; Matsunuma R; Azuma Y; Imai K; Morita T; Shinjo T
    Cancer Med; 2021 Feb; 10(3):1166-1179. PubMed ID: 33314743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric and cognitive profile of patients with DSM-IV delirium referred to an old age psychiatry consultation-liaison service.
    Jabbar F; Leonard M; Meehan K; O'Connor M; Cronin C; Reynolds P; Meaney AM; Meagher D
    Int Psychogeriatr; 2011 Sep; 23(7):1167-74. PubMed ID: 21251353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trazodone and Mianserin for Delirium: A Retrospective Chart Review.
    Kawano S; Ide K; Kodama K; Kikuchi Y; Sugihara H; Fujisawa D; Uchida H; Mimura M; Takeuchi H
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):560-564. PubMed ID: 36306393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center.
    de la Cruz M; Fan J; Yennu S; Tanco K; Shin S; Wu J; Liu D; Bruera E
    Support Care Cancer; 2015 Aug; 23(8):2427-33. PubMed ID: 25617070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First- and second-line pharmacological treatment for delirium in general hospital setting-Retrospective analysis.
    Wada K; Morita Y; Iwamoto T; Mifune Y; Nojima S
    Asian J Psychiatr; 2018 Feb; 32():50-53. PubMed ID: 29216606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial.
    Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC
    JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care.
    Spiller JA; Keen JC
    Palliat Med; 2006 Jan; 20(1):17-23. PubMed ID: 16482754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delirium in the intensive care setting and the Richmond Agitation and Sedation Scale (RASS): Drowsiness increases the risk and is subthreshold for delirium.
    Boettger S; Nuñez DG; Meyer R; Richter A; Fernandez SF; Rudiger A; Schubert M; Jenewein J
    J Psychosom Res; 2017 Dec; 103():133-139. PubMed ID: 29167040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Extrapyramidal Symptoms in Cancer Patients Referred to Palliative Care: A Multicenter Observational Study (JORTC PAL12).
    Ishiki H; Hamano J; Nagaoka H; Matsuda Y; Tokoro A; Matsuoka H; Izumi H; Sakashita A; Kizawa Y; Oyamada S; Yamaguchi T; Iwase S
    Am J Hosp Palliat Care; 2021 Jul; 38(7):823-829. PubMed ID: 32940536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis.
    Meagher DJ; Leonard M; Donnelly S; Conroy M; Adamis D; Trzepacz PT
    J Psychosom Res; 2011 Dec; 71(6):395-403. PubMed ID: 22118382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delirium Frequency and Risk Factors Among Patients With Cancer in Palliative Care Unit.
    Şenel G; Uysal N; Oguz G; Kaya M; Kadioullari N; Koçak N; Karaca S
    Am J Hosp Palliat Care; 2017 Apr; 34(3):282-286. PubMed ID: 26722008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment efficacy of neural blockade in specialized palliative care services in Japan: a multicenter audit survey.
    Tei Y; Morita T; Nakaho T; Takigawa C; Higuchi A; Suga A; Tajima T; Ikenaga M; Higuchi H; Shimoyama N; Fujimoto M
    J Pain Symptom Manage; 2008 Nov; 36(5):461-7. PubMed ID: 18504097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.